NATROX^® Oxygen Wound Therapy is a class II medical device licensed under Medical Device Directive 93/42/EEC which enables clinicians to prescribe pure humidified oxygen applied directly to a wound to assist wound healing in complex, chronic or non-healing wounds.

NATROX^® O₂ extracts oxygen from the air and delivers it through a thin flexible tube to the unique Oxygen Delivery System (ODS) which is in direct contact with the wound surface. This continuous supply of oxygen ensures an oxygen-rich environment around the wound area. NATROX^® O₂ is silent with no sensation of movement while providing a continuous flow of pure humidified oxygen.

The advanced digital platform offers a central, cloud-based hub where clinical teams can capture and access up-to-date information on wound care patients. It helps take the pain out of documentation by providing an easy digital template clinicians can follow when documenting wound progression. This can help clinical teams standardise documentation methods across care settings and improve communication.

NATROX® IQ is an online app that works on desktops, tablets, and mobile devices. The platform connects to a 3rd party software that leverages the power of AI to digitally measure wound size and depth. It also allows clinicians to oversee wound progression remotely via a telehealth feature which includes video conferencing and SMS messaging. This can help reduce nonessential clinic visits and increase convenience for both patients and clinicians.

• Point-of-care bacterial detection ^1,2

• Real-time results

• Use on all wounds, in all wound care settings

• Safe, portable, non-invasive

• A comprehensive toolkit for digital wound measurement and documentation³

In a darkened room, or using a DarkDrape™, shining a safe violet excitation light (405 nm) on a wound causes wound components (skin, slough, blood, bacteria, etc.) to fluoresce in different colours ^1-3. The i:X device displays and captures images of the most informative of these fluorescent colours. Green fluorescence from the skin provides anatomical context. Red and cyan fluorescence are associated with regions of bacterial load of >104 CFU/g ^2,3, which is typically moderate-to-heavy growth ^1-3, as demonstrated in multiple clinical studies.